nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbimazole—CYP19A1—Paclitaxel—kidney cancer	0.337	1	CbGbCtD
Carbimazole—TPO—Thyroxine (Thyroid Hormone) Production—SLC5A5—kidney cancer	0.0283	0.169	CbGpPWpGaD
Carbimazole—TPO—Thyroxine biosynthesis—SLC5A5—kidney cancer	0.0225	0.135	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—ALK—kidney cancer	0.0155	0.0926	CbGpPWpGaD
Carbimazole—TPO—Amine-derived hormones—SLC5A5—kidney cancer	0.0129	0.0773	CbGpPWpGaD
Carbimazole—CYP19A1—Ovarian Infertility Genes—SYNE2—kidney cancer	0.00816	0.0488	CbGpPWpGaD
Carbimazole—TPO—Amino acid and derivative metabolism—CCBL1—kidney cancer	0.00519	0.0311	CbGpPWpGaD
Carbimazole—CYP19A1—Tryptophan metabolism—ALDH1A1—kidney cancer	0.00334	0.02	CbGpPWpGaD
Carbimazole—CYP19A1—FSH signaling pathway—EIF4EBP1—kidney cancer	0.00297	0.0178	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—KIT—kidney cancer	0.00295	0.0176	CbGpPWpGaD
Carbimazole—CYP19A1—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	0.00219	0.0131	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—ACY1—kidney cancer	0.00212	0.0127	CbGpPWpGaD
Carbimazole—CYP19A1—Ovarian Infertility Genes—EGR1—kidney cancer	0.00203	0.0121	CbGpPWpGaD
Carbimazole—TPO—Amino acid and derivative metabolism—PSMD7—kidney cancer	0.00192	0.0115	CbGpPWpGaD
Carbimazole—TPO—Amino acid and derivative metabolism—SLC5A5—kidney cancer	0.0018	0.0108	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—VEGFA—kidney cancer	0.00176	0.0105	CbGpPWpGaD
Carbimazole—CYP19A1—FSH signaling pathway—TSC2—kidney cancer	0.00161	0.00964	CbGpPWpGaD
Carbimazole—CYP19A1—Endogenous sterols—POMC—kidney cancer	0.00154	0.00922	CbGpPWpGaD
Carbimazole—Pancytopenia—Gemcitabine—kidney cancer	0.00134	0.0027	CcSEcCtD
Carbimazole—Hepatitis—Dactinomycin—kidney cancer	0.00133	0.00268	CcSEcCtD
Carbimazole—Malaise—Vinblastine—kidney cancer	0.00133	0.00267	CcSEcCtD
Carbimazole—Angiopathy—Sorafenib—kidney cancer	0.00132	0.00267	CcSEcCtD
Carbimazole—Malaise—Everolimus—kidney cancer	0.00132	0.00266	CcSEcCtD
Carbimazole—Neutropenia—Gemcitabine—kidney cancer	0.00132	0.00265	CcSEcCtD
Carbimazole—Leukopenia—Vinblastine—kidney cancer	0.00132	0.00265	CcSEcCtD
Carbimazole—Leukopenia—Everolimus—kidney cancer	0.00131	0.00264	CcSEcCtD
Carbimazole—Stomatitis—Vincristine—kidney cancer	0.00129	0.0026	CcSEcCtD
Carbimazole—Alopecia—Sorafenib—kidney cancer	0.00129	0.0026	CcSEcCtD
Carbimazole—Angiopathy—Sunitinib—kidney cancer	0.00127	0.00257	CcSEcCtD
Carbimazole—Body temperature increased—Temsirolimus—kidney cancer	0.00127	0.00256	CcSEcCtD
Carbimazole—Liver function test abnormal—Paclitaxel—kidney cancer	0.00126	0.00254	CcSEcCtD
Carbimazole—Myalgia—Everolimus—kidney cancer	0.00125	0.00251	CcSEcCtD
Carbimazole—Arthralgia—Everolimus—kidney cancer	0.00125	0.00251	CcSEcCtD
Carbimazole—Alopecia—Sunitinib—kidney cancer	0.00124	0.0025	CcSEcCtD
Carbimazole—Haemolytic anaemia—Capecitabine—kidney cancer	0.00124	0.0025	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Everolimus—kidney cancer	0.00124	0.0025	CcSEcCtD
Carbimazole—Discomfort—Vinblastine—kidney cancer	0.00124	0.00249	CcSEcCtD
Carbimazole—Discomfort—Everolimus—kidney cancer	0.00123	0.00248	CcSEcCtD
Carbimazole—Ageusia—Doxorubicin—kidney cancer	0.00123	0.00247	CcSEcCtD
Carbimazole—Stomatitis—Gemcitabine—kidney cancer	0.00122	0.00247	CcSEcCtD
Carbimazole—CYP19A1—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.00121	0.00722	CbGpPWpGaD
Carbimazole—Myalgia—Erlotinib—kidney cancer	0.0012	0.00242	CcSEcCtD
Carbimazole—Arthralgia—Erlotinib—kidney cancer	0.0012	0.00242	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—kidney cancer	0.00119	0.00241	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—FOSL1—kidney cancer	0.00119	0.00713	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ACY1—kidney cancer	0.00119	0.00713	CbGpPWpGaD
Carbimazole—Infection—Everolimus—kidney cancer	0.00119	0.00239	CcSEcCtD
Carbimazole—CYP19A1—Tryptophan metabolism—CYP1A1—kidney cancer	0.00119	0.0071	CbGpPWpGaD
Carbimazole—Hypersensitivity—Temsirolimus—kidney cancer	0.00118	0.00239	CcSEcCtD
Carbimazole—Alopecia—Dactinomycin—kidney cancer	0.00117	0.00237	CcSEcCtD
Carbimazole—Thrombocytopenia—Vinblastine—kidney cancer	0.00117	0.00237	CcSEcCtD
Carbimazole—Nervous system disorder—Everolimus—kidney cancer	0.00117	0.00236	CcSEcCtD
Carbimazole—Agranulocytosis—Gemcitabine—kidney cancer	0.00117	0.00236	CcSEcCtD
Carbimazole—Thrombocytopenia—Everolimus—kidney cancer	0.00117	0.00236	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—ALDH1A1—kidney cancer	0.00116	0.00697	CbGpPWpGaD
Carbimazole—Angioedema—Sorafenib—kidney cancer	0.00116	0.00234	CcSEcCtD
Carbimazole—Skin disorder—Everolimus—kidney cancer	0.00116	0.00234	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of steroid hormones and vitamin D—POMC—kidney cancer	0.00115	0.0069	CbGpPWpGaD
Carbimazole—Infection—Erlotinib—kidney cancer	0.00115	0.00231	CcSEcCtD
Carbimazole—Leukopenia—Sorafenib—kidney cancer	0.00114	0.00229	CcSEcCtD
Carbimazole—Pruritus—Temsirolimus—kidney cancer	0.00114	0.00229	CcSEcCtD
Carbimazole—Haemoglobin—Gemcitabine—kidney cancer	0.00113	0.00228	CcSEcCtD
Carbimazole—Jaundice cholestatic—Doxorubicin—kidney cancer	0.00113	0.00228	CcSEcCtD
Carbimazole—Nervous system disorder—Erlotinib—kidney cancer	0.00113	0.00228	CcSEcCtD
Carbimazole—Thrombocytopenia—Erlotinib—kidney cancer	0.00113	0.00228	CcSEcCtD
Carbimazole—Haemorrhage—Gemcitabine—kidney cancer	0.00113	0.00227	CcSEcCtD
Carbimazole—Skin disorder—Erlotinib—kidney cancer	0.00112	0.00226	CcSEcCtD
Carbimazole—Pancytopenia—Paclitaxel—kidney cancer	0.00112	0.00226	CcSEcCtD
Carbimazole—Angioedema—Sunitinib—kidney cancer	0.00112	0.00225	CcSEcCtD
Carbimazole—CYP19A1—FSH signaling pathway—RAF1—kidney cancer	0.00112	0.00668	CbGpPWpGaD
Carbimazole—Neutropenia—Paclitaxel—kidney cancer	0.0011	0.00222	CcSEcCtD
Carbimazole—Leukopenia—Sunitinib—kidney cancer	0.00109	0.00221	CcSEcCtD
Carbimazole—CYP19A1—FSH signaling pathway—MTOR—kidney cancer	0.00109	0.00653	CbGpPWpGaD
Carbimazole—Musculoskeletal discomfort—Everolimus—kidney cancer	0.00109	0.00219	CcSEcCtD
Carbimazole—Myalgia—Sorafenib—kidney cancer	0.00108	0.00218	CcSEcCtD
Carbimazole—Arthralgia—Sorafenib—kidney cancer	0.00108	0.00218	CcSEcCtD
Carbimazole—Angiopathy—Vincristine—kidney cancer	0.00108	0.00217	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—kidney cancer	0.00107	0.00217	CcSEcCtD
Carbimazole—Ill-defined disorder—Dactinomycin—kidney cancer	0.00107	0.00217	CcSEcCtD
Carbimazole—Pruritus—Pazopanib—kidney cancer	0.00107	0.00216	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Erlotinib—kidney cancer	0.00105	0.00212	CcSEcCtD
Carbimazole—Alopecia—Vincristine—kidney cancer	0.00105	0.00212	CcSEcCtD
Carbimazole—Malaise—Dactinomycin—kidney cancer	0.00104	0.0021	CcSEcCtD
Carbimazole—Myalgia—Sunitinib—kidney cancer	0.00104	0.0021	CcSEcCtD
Carbimazole—Arthralgia—Sunitinib—kidney cancer	0.00104	0.0021	CcSEcCtD
Carbimazole—Leukopenia—Dactinomycin—kidney cancer	0.00104	0.00209	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—kidney cancer	0.00103	0.00208	CcSEcCtD
Carbimazole—Liver function test abnormal—Capecitabine—kidney cancer	0.00103	0.00208	CcSEcCtD
Carbimazole—Infection—Sorafenib—kidney cancer	0.00103	0.00208	CcSEcCtD
Carbimazole—Stomatitis—Paclitaxel—kidney cancer	0.00102	0.00207	CcSEcCtD
Carbimazole—Angiopathy—Gemcitabine—kidney cancer	0.00102	0.00206	CcSEcCtD
Carbimazole—Nervous system disorder—Sorafenib—kidney cancer	0.00102	0.00205	CcSEcCtD
Carbimazole—Thrombocytopenia—Sorafenib—kidney cancer	0.00102	0.00205	CcSEcCtD
Carbimazole—TPO—Metabolism—PDHB—kidney cancer	0.00101	0.00607	CbGpPWpGaD
Carbimazole—Rash—Temsirolimus—kidney cancer	0.00101	0.00204	CcSEcCtD
Carbimazole—Dermatitis—Temsirolimus—kidney cancer	0.00101	0.00204	CcSEcCtD
Carbimazole—Skin disorder—Sorafenib—kidney cancer	0.00101	0.00203	CcSEcCtD
Carbimazole—Headache—Temsirolimus—kidney cancer	0.00101	0.00203	CcSEcCtD
Carbimazole—Alopecia—Gemcitabine—kidney cancer	0.000996	0.00201	CcSEcCtD
Carbimazole—Hepatocellular injury—Doxorubicin—kidney cancer	0.000994	0.002	CcSEcCtD
Carbimazole—Infection—Sunitinib—kidney cancer	0.000991	0.002	CcSEcCtD
Carbimazole—Feeling abnormal—Vinblastine—kidney cancer	0.000988	0.00199	CcSEcCtD
Carbimazole—Myalgia—Dactinomycin—kidney cancer	0.000985	0.00199	CcSEcCtD
Carbimazole—Feeling abnormal—Everolimus—kidney cancer	0.000984	0.00198	CcSEcCtD
Carbimazole—Nervous system disorder—Sunitinib—kidney cancer	0.000979	0.00197	CcSEcCtD
Carbimazole—Thrombocytopenia—Sunitinib—kidney cancer	0.000977	0.00197	CcSEcCtD
Carbimazole—Discomfort—Dactinomycin—kidney cancer	0.000974	0.00196	CcSEcCtD
Carbimazole—Skin disorder—Sunitinib—kidney cancer	0.000969	0.00195	CcSEcCtD
Carbimazole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.000959	0.00574	CbGpPWpGaD
Carbimazole—Rash—Pazopanib—kidney cancer	0.000954	0.00192	CcSEcCtD
Carbimazole—Nausea—Temsirolimus—kidney cancer	0.000954	0.00192	CcSEcCtD
Carbimazole—Dermatitis—Pazopanib—kidney cancer	0.000953	0.00192	CcSEcCtD
Carbimazole—TPO—Metabolism—CCBL1—kidney cancer	0.000953	0.0057	CbGpPWpGaD
Carbimazole—Haemoglobin—Paclitaxel—kidney cancer	0.000948	0.00191	CcSEcCtD
Carbimazole—Headache—Pazopanib—kidney cancer	0.000948	0.00191	CcSEcCtD
Carbimazole—CYP19A1—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.000946	0.00566	CbGpPWpGaD
Carbimazole—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.000945	0.0019	CcSEcCtD
Carbimazole—Body temperature increased—Everolimus—kidney cancer	0.000944	0.0019	CcSEcCtD
Carbimazole—Haemorrhage—Paclitaxel—kidney cancer	0.000943	0.0019	CcSEcCtD
Carbimazole—Infection—Dactinomycin—kidney cancer	0.000938	0.00189	CcSEcCtD
Carbimazole—Aplastic anaemia—Doxorubicin—kidney cancer	0.000933	0.00188	CcSEcCtD
Carbimazole—Leukopenia—Vincristine—kidney cancer	0.000926	0.00187	CcSEcCtD
Carbimazole—Thrombocytopenia—Dactinomycin—kidney cancer	0.000925	0.00186	CcSEcCtD
Carbimazole—Pancytopenia—Capecitabine—kidney cancer	0.000919	0.00185	CcSEcCtD
Carbimazole—Body temperature increased—Erlotinib—kidney cancer	0.000911	0.00184	CcSEcCtD
Carbimazole—Ill-defined disorder—Gemcitabine—kidney cancer	0.00091	0.00184	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.000909	0.00183	CcSEcCtD
Carbimazole—Neutropenia—Capecitabine—kidney cancer	0.000905	0.00182	CcSEcCtD
Carbimazole—Nausea—Pazopanib—kidney cancer	0.000899	0.00181	CcSEcCtD
Carbimazole—Mouth ulceration—Doxorubicin—kidney cancer	0.000899	0.00181	CcSEcCtD
Carbimazole—CYP19A1—Ovarian Infertility Genes—CDKN1B—kidney cancer	0.000893	0.00535	CbGpPWpGaD
Carbimazole—Malaise—Gemcitabine—kidney cancer	0.000885	0.00178	CcSEcCtD
Carbimazole—Hypersensitivity—Vinblastine—kidney cancer	0.000884	0.00178	CcSEcCtD
Carbimazole—Myalgia—Vincristine—kidney cancer	0.00088	0.00178	CcSEcCtD
Carbimazole—Hypersensitivity—Everolimus—kidney cancer	0.00088	0.00177	CcSEcCtD
Carbimazole—Leukopenia—Gemcitabine—kidney cancer	0.000878	0.00177	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000861	0.00174	CcSEcCtD
Carbimazole—Angiopathy—Paclitaxel—kidney cancer	0.000856	0.00173	CcSEcCtD
Carbimazole—Pruritus—Everolimus—kidney cancer	0.000845	0.0017	CcSEcCtD
Carbimazole—Jaundice—Capecitabine—kidney cancer	0.000841	0.0017	CcSEcCtD
Carbimazole—Stomatitis—Capecitabine—kidney cancer	0.000841	0.0017	CcSEcCtD
Carbimazole—Infection—Vincristine—kidney cancer	0.000838	0.00169	CcSEcCtD
Carbimazole—Myalgia—Gemcitabine—kidney cancer	0.000835	0.00168	CcSEcCtD
Carbimazole—Arthralgia—Gemcitabine—kidney cancer	0.000835	0.00168	CcSEcCtD
Carbimazole—Alopecia—Paclitaxel—kidney cancer	0.000834	0.00168	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000829	0.00167	CcSEcCtD
Carbimazole—Nervous system disorder—Vincristine—kidney cancer	0.000828	0.00167	CcSEcCtD
Carbimazole—Thrombocytopenia—Vincristine—kidney cancer	0.000826	0.00167	CcSEcCtD
Carbimazole—TPO—Metabolism—PPAT—kidney cancer	0.000826	0.00494	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GLIPR1—kidney cancer	0.000826	0.00494	CbGpPWpGaD
Carbimazole—Discomfort—Gemcitabine—kidney cancer	0.000825	0.00166	CcSEcCtD
Carbimazole—Urticaria—Sorafenib—kidney cancer	0.000824	0.00166	CcSEcCtD
Carbimazole—Body temperature increased—Sorafenib—kidney cancer	0.00082	0.00165	CcSEcCtD
Carbimazole—Pruritus—Erlotinib—kidney cancer	0.000815	0.00164	CcSEcCtD
Carbimazole—CYP19A1—FSH signaling pathway—MAPK3—kidney cancer	0.000805	0.00482	CbGpPWpGaD
Carbimazole—Agranulocytosis—Capecitabine—kidney cancer	0.000805	0.00162	CcSEcCtD
Carbimazole—Infection—Gemcitabine—kidney cancer	0.000795	0.0016	CcSEcCtD
Carbimazole—Body temperature increased—Sunitinib—kidney cancer	0.000789	0.00159	CcSEcCtD
Carbimazole—Nervous system disorder—Gemcitabine—kidney cancer	0.000785	0.00158	CcSEcCtD
Carbimazole—Thrombocytopenia—Gemcitabine—kidney cancer	0.000784	0.00158	CcSEcCtD
Carbimazole—Feeling abnormal—Dactinomycin—kidney cancer	0.000778	0.00157	CcSEcCtD
Carbimazole—Haemoglobin—Capecitabine—kidney cancer	0.000778	0.00157	CcSEcCtD
Carbimazole—Skin disorder—Gemcitabine—kidney cancer	0.000778	0.00157	CcSEcCtD
Carbimazole—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.000778	0.00465	CbGpPWpGaD
Carbimazole—Haemorrhage—Capecitabine—kidney cancer	0.000774	0.00156	CcSEcCtD
Carbimazole—Hepatitis—Capecitabine—kidney cancer	0.000774	0.00156	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000769	0.00155	CcSEcCtD
Carbimazole—TPO—Metabolism—FH—kidney cancer	0.000768	0.0046	CbGpPWpGaD
Carbimazole—TPO—Metabolism—APRT—kidney cancer	0.000768	0.0046	CbGpPWpGaD
Carbimazole—CYP19A1—FSH signaling pathway—MAPK1—kidney cancer	0.000766	0.00458	CbGpPWpGaD
Carbimazole—Hypersensitivity—Sorafenib—kidney cancer	0.000764	0.00154	CcSEcCtD
Carbimazole—Ill-defined disorder—Paclitaxel—kidney cancer	0.000762	0.00154	CcSEcCtD
Carbimazole—Rash—Everolimus—kidney cancer	0.000753	0.00152	CcSEcCtD
Carbimazole—Dermatitis—Everolimus—kidney cancer	0.000753	0.00152	CcSEcCtD
Carbimazole—Headache—Vinblastine—kidney cancer	0.000751	0.00151	CcSEcCtD
Carbimazole—Angioedema—Paclitaxel—kidney cancer	0.00075	0.00151	CcSEcCtD
Carbimazole—Headache—Everolimus—kidney cancer	0.000748	0.00151	CcSEcCtD
Carbimazole—Body temperature increased—Dactinomycin—kidney cancer	0.000747	0.00151	CcSEcCtD
Carbimazole—Malaise—Paclitaxel—kidney cancer	0.000741	0.00149	CcSEcCtD
Carbimazole—Leukopenia—Paclitaxel—kidney cancer	0.000735	0.00148	CcSEcCtD
Carbimazole—Hypersensitivity—Sunitinib—kidney cancer	0.000735	0.00148	CcSEcCtD
Carbimazole—Pruritus—Sorafenib—kidney cancer	0.000734	0.00148	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000729	0.00147	CcSEcCtD
Carbimazole—Rash—Erlotinib—kidney cancer	0.000727	0.00147	CcSEcCtD
Carbimazole—Dermatitis—Erlotinib—kidney cancer	0.000726	0.00146	CcSEcCtD
Carbimazole—TPO—Metabolism—GPC3—kidney cancer	0.000722	0.00432	CbGpPWpGaD
Carbimazole—Headache—Erlotinib—kidney cancer	0.000722	0.00146	CcSEcCtD
Carbimazole—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	0.000715	0.00428	CbGpPWpGaD
Carbimazole—Nausea—Vinblastine—kidney cancer	0.000712	0.00144	CcSEcCtD
Carbimazole—Nausea—Everolimus—kidney cancer	0.00071	0.00143	CcSEcCtD
Carbimazole—Pruritus—Sunitinib—kidney cancer	0.000706	0.00142	CcSEcCtD
Carbimazole—TPO—Metabolism—CA2—kidney cancer	0.000703	0.0042	CbGpPWpGaD
Carbimazole—Angiopathy—Capecitabine—kidney cancer	0.000702	0.00142	CcSEcCtD
Carbimazole—Myalgia—Paclitaxel—kidney cancer	0.000699	0.00141	CcSEcCtD
Carbimazole—Arthralgia—Paclitaxel—kidney cancer	0.000699	0.00141	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—TSC1—kidney cancer	0.000698	0.00417	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—ANXA1—kidney cancer	0.000698	0.00417	CbGpPWpGaD
Carbimazole—Hypersensitivity—Dactinomycin—kidney cancer	0.000696	0.0014	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000694	0.0014	CcSEcCtD
Carbimazole—Discomfort—Paclitaxel—kidney cancer	0.000691	0.00139	CcSEcCtD
Carbimazole—Nausea—Erlotinib—kidney cancer	0.000685	0.00138	CcSEcCtD
Carbimazole—TPO—Metabolism—ALAD—kidney cancer	0.000685	0.0041	CbGpPWpGaD
Carbimazole—Alopecia—Capecitabine—kidney cancer	0.000684	0.00138	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—GSTT1—kidney cancer	0.000684	0.00409	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—AURKA—kidney cancer	0.000679	0.00406	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ST3GAL2—kidney cancer	0.000668	0.004	CbGpPWpGaD
Carbimazole—Body temperature increased—Vincristine—kidney cancer	0.000667	0.00135	CcSEcCtD
Carbimazole—Liver function test abnormal—Doxorubicin—kidney cancer	0.000666	0.00134	CcSEcCtD
Carbimazole—Infection—Paclitaxel—kidney cancer	0.000666	0.00134	CcSEcCtD
Carbimazole—Feeling abnormal—Gemcitabine—kidney cancer	0.00066	0.00133	CcSEcCtD
Carbimazole—Nervous system disorder—Paclitaxel—kidney cancer	0.000657	0.00133	CcSEcCtD
Carbimazole—Thrombocytopenia—Paclitaxel—kidney cancer	0.000656	0.00132	CcSEcCtD
Carbimazole—Rash—Sorafenib—kidney cancer	0.000654	0.00132	CcSEcCtD
Carbimazole—Dermatitis—Sorafenib—kidney cancer	0.000653	0.00132	CcSEcCtD
Carbimazole—TPO—Metabolism—ALDH1A1—kidney cancer	0.000653	0.00391	CbGpPWpGaD
Carbimazole—Skin disorder—Paclitaxel—kidney cancer	0.000651	0.00131	CcSEcCtD
Carbimazole—Headache—Sorafenib—kidney cancer	0.00065	0.00131	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—PTGS1—kidney cancer	0.000641	0.00384	CbGpPWpGaD
Carbimazole—Body temperature increased—Gemcitabine—kidney cancer	0.000633	0.00128	CcSEcCtD
Carbimazole—Rash—Sunitinib—kidney cancer	0.000629	0.00127	CcSEcCtD
Carbimazole—Dermatitis—Sunitinib—kidney cancer	0.000629	0.00127	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—PAK1—kidney cancer	0.000626	0.00375	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PGK1—kidney cancer	0.000626	0.00375	CbGpPWpGaD
Carbimazole—TPO—Metabolism—SLC5A3—kidney cancer	0.000626	0.00375	CbGpPWpGaD
Carbimazole—Ill-defined disorder—Capecitabine—kidney cancer	0.000625	0.00126	CcSEcCtD
Carbimazole—Headache—Sunitinib—kidney cancer	0.000625	0.00126	CcSEcCtD
Carbimazole—Hypersensitivity—Vincristine—kidney cancer	0.000622	0.00125	CcSEcCtD
Carbimazole—Eosinophilia—Doxorubicin—kidney cancer	0.000617	0.00124	CcSEcCtD
Carbimazole—Nausea—Sorafenib—kidney cancer	0.000616	0.00124	CcSEcCtD
Carbimazole—TPO—Metabolism—LDHB—kidney cancer	0.000614	0.00368	CbGpPWpGaD
Carbimazole—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000611	0.00123	CcSEcCtD
Carbimazole—Malaise—Capecitabine—kidney cancer	0.000608	0.00123	CcSEcCtD
Carbimazole—Leukopenia—Capecitabine—kidney cancer	0.000603	0.00122	CcSEcCtD
Carbimazole—Rash—Dactinomycin—kidney cancer	0.000596	0.0012	CcSEcCtD
Carbimazole—Nausea—Sunitinib—kidney cancer	0.000593	0.0012	CcSEcCtD
Carbimazole—Pancytopenia—Doxorubicin—kidney cancer	0.000592	0.00119	CcSEcCtD
Carbimazole—Neutropenia—Doxorubicin—kidney cancer	0.000583	0.00118	CcSEcCtD
Carbimazole—CYP19A1—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.00058	0.00347	CbGpPWpGaD
Carbimazole—Arthralgia—Capecitabine—kidney cancer	0.000574	0.00116	CcSEcCtD
Carbimazole—Myalgia—Capecitabine—kidney cancer	0.000574	0.00116	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.00057	0.00115	CcSEcCtD
Carbimazole—Discomfort—Capecitabine—kidney cancer	0.000567	0.00114	CcSEcCtD
Carbimazole—Pruritus—Gemcitabine—kidney cancer	0.000566	0.00114	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.000565	0.00338	CbGpPWpGaD
Carbimazole—Nausea—Dactinomycin—kidney cancer	0.000561	0.00113	CcSEcCtD
Carbimazole—Feeling abnormal—Paclitaxel—kidney cancer	0.000552	0.00111	CcSEcCtD
Carbimazole—Infection—Capecitabine—kidney cancer	0.000546	0.0011	CcSEcCtD
Carbimazole—Jaundice—Doxorubicin—kidney cancer	0.000542	0.00109	CcSEcCtD
Carbimazole—Stomatitis—Doxorubicin—kidney cancer	0.000542	0.00109	CcSEcCtD
Carbimazole—Nervous system disorder—Capecitabine—kidney cancer	0.000539	0.00109	CcSEcCtD
Carbimazole—Thrombocytopenia—Capecitabine—kidney cancer	0.000539	0.00109	CcSEcCtD
Carbimazole—Skin disorder—Capecitabine—kidney cancer	0.000534	0.00108	CcSEcCtD
Carbimazole—Urticaria—Paclitaxel—kidney cancer	0.000533	0.00107	CcSEcCtD
Carbimazole—TPO—Metabolism—CA9—kidney cancer	0.000532	0.00319	CbGpPWpGaD
Carbimazole—Rash—Vincristine—kidney cancer	0.000532	0.00107	CcSEcCtD
Carbimazole—Dermatitis—Vincristine—kidney cancer	0.000532	0.00107	CcSEcCtD
Carbimazole—Body temperature increased—Paclitaxel—kidney cancer	0.00053	0.00107	CcSEcCtD
Carbimazole—Headache—Vincristine—kidney cancer	0.000529	0.00107	CcSEcCtD
Carbimazole—Agranulocytosis—Doxorubicin—kidney cancer	0.000519	0.00105	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—BRCA2—kidney cancer	0.000514	0.00308	CbGpPWpGaD
Carbimazole—Rash—Gemcitabine—kidney cancer	0.000505	0.00102	CcSEcCtD
Carbimazole—Dermatitis—Gemcitabine—kidney cancer	0.000504	0.00102	CcSEcCtD
Carbimazole—Haemoglobin—Doxorubicin—kidney cancer	0.000502	0.00101	CcSEcCtD
Carbimazole—Headache—Gemcitabine—kidney cancer	0.000502	0.00101	CcSEcCtD
Carbimazole—Nausea—Vincristine—kidney cancer	0.000501	0.00101	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000501	0.00101	CcSEcCtD
Carbimazole—Haemorrhage—Doxorubicin—kidney cancer	0.000499	0.00101	CcSEcCtD
Carbimazole—Hepatitis—Doxorubicin—kidney cancer	0.000499	0.00101	CcSEcCtD
Carbimazole—Hypersensitivity—Paclitaxel—kidney cancer	0.000494	0.000996	CcSEcCtD
Carbimazole—Nausea—Gemcitabine—kidney cancer	0.000476	0.000959	CcSEcCtD
Carbimazole—Pruritus—Paclitaxel—kidney cancer	0.000474	0.000956	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—GSTP1—kidney cancer	0.000474	0.00284	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—GSTP1—kidney cancer	0.000468	0.0028	CbGpPWpGaD
Carbimazole—Feeling abnormal—Capecitabine—kidney cancer	0.000453	0.000914	CcSEcCtD
Carbimazole—Angiopathy—Doxorubicin—kidney cancer	0.000453	0.000913	CcSEcCtD
Carbimazole—TPO—Metabolism—CRABP1—kidney cancer	0.000453	0.00271	CbGpPWpGaD
Carbimazole—Alopecia—Doxorubicin—kidney cancer	0.000441	0.000889	CcSEcCtD
Carbimazole—Urticaria—Capecitabine—kidney cancer	0.000437	0.000881	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—GSTM1—kidney cancer	0.000436	0.00261	CbGpPWpGaD
Carbimazole—Body temperature increased—Capecitabine—kidney cancer	0.000435	0.000877	CcSEcCtD
Carbimazole—CYP19A1—Metapathway biotransformation—GSTM1—kidney cancer	0.00043	0.00257	CbGpPWpGaD
Carbimazole—Rash—Paclitaxel—kidney cancer	0.000423	0.000852	CcSEcCtD
Carbimazole—Dermatitis—Paclitaxel—kidney cancer	0.000422	0.000851	CcSEcCtD
Carbimazole—TPO—Metabolism—ITPR2—kidney cancer	0.000421	0.00252	CbGpPWpGaD
Carbimazole—Headache—Paclitaxel—kidney cancer	0.00042	0.000847	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—CYP1A1—kidney cancer	0.000413	0.00247	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—CYP1A1—kidney cancer	0.000407	0.00244	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—TSC2—kidney cancer	0.000407	0.00243	CbGpPWpGaD
Carbimazole—Hypersensitivity—Capecitabine—kidney cancer	0.000405	0.000817	CcSEcCtD
Carbimazole—Ill-defined disorder—Doxorubicin—kidney cancer	0.000403	0.000813	CcSEcCtD
Carbimazole—Nausea—Paclitaxel—kidney cancer	0.000398	0.000803	CcSEcCtD
Carbimazole—Malaise—Doxorubicin—kidney cancer	0.000392	0.00079	CcSEcCtD
Carbimazole—Pruritus—Capecitabine—kidney cancer	0.000389	0.000785	CcSEcCtD
Carbimazole—Leukopenia—Doxorubicin—kidney cancer	0.000389	0.000784	CcSEcCtD
Carbimazole—TPO—Metabolism—ACHE—kidney cancer	0.000384	0.0023	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GSTT1—kidney cancer	0.000384	0.0023	CbGpPWpGaD
Carbimazole—Arthralgia—Doxorubicin—kidney cancer	0.00037	0.000746	CcSEcCtD
Carbimazole—Myalgia—Doxorubicin—kidney cancer	0.00037	0.000746	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000367	0.000741	CcSEcCtD
Carbimazole—Discomfort—Doxorubicin—kidney cancer	0.000365	0.000737	CcSEcCtD
Carbimazole—TPO—Metabolism—SCARB1—kidney cancer	0.000363	0.00217	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ACY1—kidney cancer	0.000363	0.00217	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PTGS1—kidney cancer	0.00036	0.00215	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PSMD7—kidney cancer	0.000353	0.00211	CbGpPWpGaD
Carbimazole—Infection—Doxorubicin—kidney cancer	0.000352	0.00071	CcSEcCtD
Carbimazole—Nervous system disorder—Doxorubicin—kidney cancer	0.000348	0.000701	CcSEcCtD
Carbimazole—Thrombocytopenia—Doxorubicin—kidney cancer	0.000347	0.0007	CcSEcCtD
Carbimazole—Rash—Capecitabine—kidney cancer	0.000347	0.000699	CcSEcCtD
Carbimazole—Dermatitis—Capecitabine—kidney cancer	0.000347	0.000699	CcSEcCtD
Carbimazole—Headache—Capecitabine—kidney cancer	0.000345	0.000695	CcSEcCtD
Carbimazole—Skin disorder—Doxorubicin—kidney cancer	0.000344	0.000694	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—BRAF—kidney cancer	0.000337	0.00202	CbGpPWpGaD
Carbimazole—TPO—Metabolism—BCHE—kidney cancer	0.000334	0.002	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CDH1—kidney cancer	0.00033	0.00198	CbGpPWpGaD
Carbimazole—TPO—Metabolism—SLC5A5—kidney cancer	0.00033	0.00198	CbGpPWpGaD
Carbimazole—Nausea—Capecitabine—kidney cancer	0.000327	0.000659	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000323	0.000651	CcSEcCtD
Carbimazole—TPO—Metabolism—SLC2A1—kidney cancer	0.000319	0.00191	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	0.00031	0.00185	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PDHB—kidney cancer	0.000309	0.00185	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—POMC—kidney cancer	0.000308	0.00184	CbGpPWpGaD
Carbimazole—Feeling abnormal—Doxorubicin—kidney cancer	0.000292	0.000589	CcSEcCtD
Carbimazole—CYP19A1—Metabolism—CCBL1—kidney cancer	0.00029	0.00174	CbGpPWpGaD
Carbimazole—Urticaria—Doxorubicin—kidney cancer	0.000282	0.000568	CcSEcCtD
Carbimazole—Body temperature increased—Doxorubicin—kidney cancer	0.00028	0.000565	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—MTOR—kidney cancer	0.000275	0.00165	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GSTP1—kidney cancer	0.000266	0.00159	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	0.000263	0.00157	CbGpPWpGaD
Carbimazole—Hypersensitivity—Doxorubicin—kidney cancer	0.000261	0.000527	CcSEcCtD
Carbimazole—TPO—Metabolism—ABCB1—kidney cancer	0.000252	0.00151	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GLIPR1—kidney cancer	0.000252	0.00151	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PPAT—kidney cancer	0.000252	0.00151	CbGpPWpGaD
Carbimazole—Pruritus—Doxorubicin—kidney cancer	0.000251	0.000506	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	0.000249	0.00149	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CCND1—kidney cancer	0.000246	0.00147	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	0.000246	0.00147	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—JUN—kidney cancer	0.000246	0.00147	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GSTM1—kidney cancer	0.000244	0.00146	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—kidney cancer	0.000244	0.00146	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—PTEN—kidney cancer	0.000238	0.00142	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—FH—kidney cancer	0.000234	0.0014	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—APRT—kidney cancer	0.000234	0.0014	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CYP1A1—kidney cancer	0.000232	0.00139	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	0.000229	0.00137	CbGpPWpGaD
Carbimazole—Rash—Doxorubicin—kidney cancer	0.000224	0.000451	CcSEcCtD
Carbimazole—Dermatitis—Doxorubicin—kidney cancer	0.000223	0.00045	CcSEcCtD
Carbimazole—Headache—Doxorubicin—kidney cancer	0.000222	0.000448	CcSEcCtD
Carbimazole—CYP19A1—Metabolism—GPC3—kidney cancer	0.00022	0.00132	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—kidney cancer	0.000215	0.00129	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CA2—kidney cancer	0.000214	0.00128	CbGpPWpGaD
Carbimazole—Nausea—Doxorubicin—kidney cancer	0.000211	0.000425	CcSEcCtD
Carbimazole—CYP19A1—Metabolism—ALAD—kidney cancer	0.000209	0.00125	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ST3GAL2—kidney cancer	0.000204	0.00122	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ALDH1A1—kidney cancer	0.000199	0.00119	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—MYC—kidney cancer	0.000198	0.00118	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—kidney cancer	0.000193	0.00116	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PGK1—kidney cancer	0.000191	0.00114	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SLC5A3—kidney cancer	0.000191	0.00114	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—LDHB—kidney cancer	0.000187	0.00112	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—KRAS—kidney cancer	0.000183	0.00109	CbGpPWpGaD
Carbimazole—TPO—Metabolism—POMC—kidney cancer	0.000173	0.00103	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CA9—kidney cancer	0.000162	0.000971	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—TP53—kidney cancer	0.000162	0.000971	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	0.000159	0.000949	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CRABP1—kidney cancer	0.000138	0.000826	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PTGS2—kidney cancer	0.000138	0.000825	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ITPR2—kidney cancer	0.000128	0.000768	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PTEN—kidney cancer	0.00012	0.000719	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	0.000118	0.000708	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSTT1—kidney cancer	0.000117	0.0007	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ACHE—kidney cancer	0.000117	0.0007	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SCARB1—kidney cancer	0.000111	0.000663	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PTGS1—kidney cancer	0.00011	0.000656	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PSMD7—kidney cancer	0.000107	0.000643	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—BCHE—kidney cancer	0.000102	0.00061	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SLC5A5—kidney cancer	0.000101	0.000602	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SLC2A1—kidney cancer	9.72e-05	0.000582	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	9.43e-05	0.000564	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PIK3CA—kidney cancer	8.48e-05	0.000507	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	8.23e-05	0.000492	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSTP1—kidney cancer	8.11e-05	0.000485	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ABCB1—kidney cancer	7.67e-05	0.000459	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSTM1—kidney cancer	7.45e-05	0.000446	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CYP1A1—kidney cancer	7.06e-05	0.000423	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.8e-05	0.000347	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—POMC—kidney cancer	5.27e-05	0.000315	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PTGS2—kidney cancer	4.2e-05	0.000251	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PTEN—kidney cancer	3.66e-05	0.000219	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PIK3CA—kidney cancer	2.58e-05	0.000155	CbGpPWpGaD
